| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785734 | Cancer Treatment and Research Communications | 2018 | 6 Pages |
Abstract
In Stage I-III TNBC patients receiving trimodality therapy, TFT (NAC or surgery) and TTC do not impact short-term survival if TTC is <18 months.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
K.E. Larson, S.R. Grobmyer, M. Karafa, D. Pratt,